Skip to content
Search

Latest Stories

Ready to Pay Dues If Essar Steel Bid Accepted: ArcelorMittal to India’s Top Court

Multinational steel business giant, ArcelorMittal told India’s top court, supreme court that it would lift the escrow on £744.85 million and ready to pay the money of Uttam Galva and KSS Petron in which LN Mittal is classified as a promoter, if it permitted to bid with success for Essar Steel.

Senior advocate, Harish Salve told the Supreme Court bench on Thursday that the ArcelorMittal will pay the sum if the bid for Essar Steel is accepted.


Last week, the National Company Law Appellate Tribunal (NCLAT) had ruled that ArcelorMittal's second bid for Essar Steel would be eligible only if it takes necessary steps to repay all dues of the two companies.

In a response to the NCLAT ruling, ArcelorMittal filed a petition before the supreme court, stressing that no bank had ever made a claim against it and its promoters had given no personal assurance for any company.

According to a report published on India’s business daily, The Economic Times, senior advocate Harish Salve before the supreme court bench consisting of Justices RF Nariman and Indu Malhotra told, Arcelor had “deep pockets" and “had made provisions for the money.” "But we can't pay for them (Uttam Galva, KSS Petron) under the law. It will immediately become taxable income in the hands of the company if I pay without any consideration.”

"We have to arrive at a structure. You say pay - we will. But it is not as easy as that. Sufficient provision (for payment of debt) should be treated on par with payment. These are listed companies. There are regulatory hurdles in payment," the newspaper quoted Salve as saying.

In an argument, Salve also noted and criticised Numetal's rival bid for Essar Steel, which obtained the NCLAT's green signal for bidding. He said the company had at least £4.78 billion in the form of non-performing assets last year. The sum that would have moved up when we add interest rate also.

Salve also highlighted saying, ArcelorMittal's bid was far more than Numetal's. He also blamed that it was a way to permit the past promoters (Ruias) circle back in an opaque fashion. However, the lawyer noted that his client, Arcelor didn’t oppose the offer made by another corporate giant- Vedanta.

Earlier, Essar Steel’s lenders rejected the Numetal’s first bid as 25 per cent share owned by Rewant Ruja, the son of Essar Steel fonder Ravi Ruia, since he was considered as a related party. India’s Insolvency and Bankruptcy Code (IBC) doesn't permits the involvement of the persons in bidding who connected to businesses which have defaulted on debt. JSW Steel bought out this disputatious share before second round of bidding for Essar Steel.

Eassar Steel’s Committee of Creditors are awaiting the supreme court’s judgement as ArcelorMittal is its bid sum of £ 4.46bn followed by Numetal’s £3.93 bn and Vedanta’s bid in between £3.19 and £3.72bn.

Salve has also pointed number of loopholes in Indian insolvency law and asked the judges bench to block them immediately. Justice Nariman agreed, saying, "The process is wrong from the top to bottom.”

The Essar Steel, which has the third highest debt pile around £5.21bn among the first 12 companies identified by India’s central bank Reserve Bank of India (RBI) for insolvency proceedings.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less